6120c75a-75d8-4cfc-ae86-7a20a8766f7d.jpeg
Use and standard dose
analyse_media
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
I have enough information to provide a comprehensive answer. Here is the full breakdown of every medication on the chart with uses and standard doses:
XV. Current Medication Chart - Analysis
A) Antibiotics
| # | Drug (Generic) | Prescribed Dose & Route | Standard Adult Dose | Frequency |
|---|---|---|---|---|
| 1 | Inj. Augmentin (Amoxicillin-Clavulanate) | 1.2 mg IV | 1.2 g IV (1000 mg amoxicillin + 200 mg clavulanate) | BD (twice daily) |
| 2 | Inj. Metronidazole | 500 mg IV | 500 mg IV every 8 hours (TID) | TID |
| 3 | Inj. Magnex Forte (Cefoperazone-Sulbactam) | 1 g IV | 1-2 g IV per dose (ratio 1:1 cefoperazone:sulbactam) | TID |
Note: The chart reads "1.2 mg" for Augmentin - this is almost certainly a handwriting error. The correct standard IV dose is 1.2 g (grams), which is the standard vial formulation worldwide. The dose as written (1.2 milligrams) would be sub-therapeutic.
B) Other Medications
| # | Drug (Generic) | Prescribed Dose & Route | Standard Dose | Frequency |
|---|---|---|---|---|
| 4 | Inj. Glapan / Pantop (Pantoprazole) | 40 mg IV | 40 mg IV OD (standard); 80 mg bolus + infusion for active GI bleed | OD (once daily) |
| 5 | Tab. Deriphyllin (Theophylline + Etofylline) | 150 mg oral | 150-200 mg BD (theophylline component ~50 mg per tab) - sustained release 200-300 mg BD | BD |
| 6 | Neb. Duolin (Ipratropium Bromide + Levosalbutamol) | 1 puff | 1 unit dose vial via nebulizer = ipratropium 500 mcg + levosalbutamol 1.25 mg | BD |
| 7 | Otrivin (Xylometazoline Nasal Drops) | -- | 0.05% drops (children) / 0.1% drops (adults), 2-3 drops per nostril | TID |
Summary of Uses
| Drug | Primary Indication (likely context here) |
|---|---|
| Amoxicillin-Clavulanate | Broad-spectrum antibiotic - covers gram-positive, gram-negative, anaerobes |
| Metronidazole | Anaerobic bacterial coverage, anti-protozoal |
| Cefoperazone-Sulbactam | Extended-spectrum beta-lactam - resistant gram-negative infections |
| Pantoprazole | Gastroprotection (stress ulcer prophylaxis in ICU/ward setting) |
| Deriphyllin (Theophylline) | Bronchodilator for COPD/asthma - used when inhaler response is inadequate |
| Duolin Nebulizer | Acute bronchospasm relief - dual bronchodilator (anticholinergic + beta-2 agonist) |
| Otrivin (Xylometazoline) | Nasal decongestant - reduces nasal congestion, TID use |
Clinical Context
The medication profile suggests a patient with a respiratory condition (likely COPD exacerbation or severe asthma with superimposed infection), receiving:
- Triple antibiotic cover (suggesting polymicrobial or hospital-acquired infection)
- Dual bronchodilator therapy (Duolin + Deriphyllin)
- Gastroprotection with pantoprazole
- Nasal decongestant for upper airway involvement
The discharge medications (Deriphyllin BD, Pantoprazole BD, Otrivin TID) confirm ongoing management of the respiratory and upper airway condition after hospital discharge.
This is a shared conversation. Sign in to Orris to start your own chat.